Co-Authors
This is a "connection" page, showing publications co-authored by Evgeny Sidorov and Dharambir Sanghera.
Connection Strength
5.282
-
Difference in acute and chronic stage ischemic stroke metabolic markers with controls. J Stroke Cerebrovasc Dis. 2023 Aug; 32(8):107211.
Score: 0.889
-
Comparison of Acute and Chronic Stage Ischemic Stroke Metabolome with Controls. Res Sq. 2023 Jan 30.
Score: 0.867
-
Global Metabolomic Profiling Reveals Disrupted Lipid and Amino Acid Metabolism Between the Acute and Chronic Stages of Ischemic Stroke. J Stroke Cerebrovasc Dis. 2022 Apr; 31(4):106320.
Score: 0.808
-
Novel Metabolites as Potential Indicators of Ischemic Infarction Volume: a Pilot Study. Transl Stroke Res. 2021 10; 12(5):778-784.
Score: 0.744
-
Potential Metabolite Biomarkers for Acute Versus Chronic Stage of Ischemic Stroke: A Pilot Study. J Stroke Cerebrovasc Dis. 2020 Apr; 29(4):104618.
Score: 0.702
-
Improving Stroke Outcome Prediction Using Molecular and Machine Learning Approaches in Large Vessel Occlusion. J Clin Med. 2024 Oct 03; 13(19).
Score: 0.243
-
Contribution of circulating Mfge8 to human T2DM and cardiovascular disease. Gene. 2024 Nov 15; 927:148712.
Score: 0.238
-
Discovery and validation of circulating stroke metabolites by NMR-based analyses using patients from the MISS and UK Biobank. Neurochem Int. 2023 Oct; 169:105588.
Score: 0.224
-
Ethnic differences in ApoC-III concentration and the risk of cardiovascular disease: No evidence for the cardioprotective role of rare/loss of function APOC3 variants in non-Europeans. Am Heart J Plus. 2022 Jan; 13.
Score: 0.204
-
APOC3 genetic variation, serum triglycerides, and risk of coronary artery disease in Asian Indians, Europeans, and other ethnic groups. Lipids Health Dis. 2021 Sep 21; 20(1):113.
Score: 0.197
-
Biomarker for Ischemic Stroke Using Metabolome: A Clinician Perspective. J Stroke. 2019 Jan; 21(1):31-41.
Score: 0.164